SLAIN1

Across TCGA pan-cancer cohorts, SLAIN1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SLAIN1 data layer compared with 22 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher SLAIN1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated SLAIN1 expression acts as an unfavorable survival marker, although some lineages such as UCEC and LSCC show a favorable association.

UCEC, LSCC, and GBM are the cancer types where SLAIN1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	II,III,IV	1.000	0.584	.011	20	view →
LSCC	OS	Tertile	III,IV	0.916	0.533	.018	10	view →
GBM	OS	Tertile	All	0.686	0.975	.004	7	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

SLAIN1–UCEC (DFS)

Open the UCEC breakdown →